EASL Policy Statement: Drug Use and the Global Hepatitis C Elimination Goal

August 2020—The European Association for the Study of the Liver (EASL) made a bold policy statement, based on a science-based policy brief, to lift treatment barriers and decriminalize drug use as part of elimination strategies.

EASL recommends “that all barriers to the uptake of the continuum of care by PWID need to be removed by changing policies and discrimination that hinder access, including the criminalisation of minor, non-violent drug offences. and to adopt an approach based on public health promotion, respect for human rights and evidence.”

Read the policy statement and full policy brief here.